Search Login Register

Chondrosarcoma Summary

Description: A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)

Also Known As: Chondrosarcomas

Networked: 1670 relevant articles (37 outcomes, 192 trials/studies) for this Disease

Key Drugs and Agents for Chondrosarcoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Protons (Proton) : 5 outcomes 7 studies in 45 results : IBA
  2. Carbon : 3 outcomes 7 studies in 18 results : IBA
  3. DNA (Deoxyribonucleic Acid) : 1 outcome 6 studies in 50 results : IBA
  4. Collagen : 1 outcome 6 studies in 46 results : IBA
  5. Phosphotransferases (Kinase) : 1 outcome 3 studies in 26 results : IBA
  6. Doxorubicin (Adriamycin) : 1 outcome 2 studies in 19 results : FDA 12 Generic
  7. Dermatofibrosarcoma protuberans : 1 outcome 2 studies in 14 results : IBA
  8. Nitric Oxide (Nitrogen Monoxide) : 1 outcome 2 studies in 7 results : FDA 1
  9. Parathyroid Hormone-Related Protein : 1 outcome 1 study in 12 results : IBA
  10. Ions : 1 outcome 1 study in 10 results : IBA
Show All >>

Diseases Related to Chondrosarcoma

  1. Neoplasms (Cancer)
  2. Chordoma
  3. Osteosarcoma (Osteogenic Sarcoma)
  4. Sarcoma (Soft Tissue Sarcoma)
  5. Liposarcoma
Show All >>

Key Therapies for Chondrosarcoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 8 outcomes 4 studies in 131 results
  2. Radiotherapy : 3 outcomes 9 studies in 102 results
  3. Curettage : 3 outcomes 1 study in 32 results
  4. Cryosurgery : 1 outcome 1 study in 10 results
  5. Aftercare (After-Treatment) : 1 outcome in 11 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.